115 related articles for article (PubMed ID: 358421)
1. B- and T-cell markers in lymphoproliferative disorders with blood and bone marrow involvement.
Katz J; Lea R; Livni N; Lewis D; Lynch SR; Skikne B; Bezwoda W
S Afr Med J; 1978 May; 53(20):789-92. PubMed ID: 358421
[TBL] [Abstract][Full Text] [Related]
2. Detection of T and B cell populations in some lymphoproliferative disorders.
Herzog P; Stöckbauer P
Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
[TBL] [Abstract][Full Text] [Related]
3. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
Pinkus GS; Said JW
Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
Brouet JC; Labaume S; Seligmann M
Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
[TBL] [Abstract][Full Text] [Related]
5. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
6. Current concepts in immunology: Cell-surface markers in lymphoproliferative disease.
Aisenberg AC
N Engl J Med; 1981 Feb; 304(6):331-6. PubMed ID: 6969365
[No Abstract] [Full Text] [Related]
7. Immunological identification of peripheral-blood lymphocytes from patients with lymphoproliferative disorders in Nigeria. II. Chronic lymphocytic leukaemia (CLL).
Ukaejiofo EO; Sagoe AS; Osunkoya BO
Afr J Med Med Sci; 1983; 12(3-4):197-202. PubMed ID: 6326554
[TBL] [Abstract][Full Text] [Related]
8. Hairy cell leukemia and other "hairy-cell" lymphoproliferative disorders (LPD-HC): the significance of morphologic, histologic and immunologic studies.
Yavorkovsky LL; Gipsh NM; Karminskaya NM; Udris OYu ; Nikulshin SV; Yavorkovsky LI
Neoplasma; 1990; 37(4):439-44. PubMed ID: 2234204
[TBL] [Abstract][Full Text] [Related]
9. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
10. Immunological identification of peripheral-blood lymphocytes from patients with lymphoproliferative disorders in Nigeria. I. Acute lymphocytic leukaemia (ALL).
Ukaejiofo EO; Sagoe AS; Osunkoya BO
Afr J Med Med Sci; 1983; 12(3-4):187-95. PubMed ID: 6326553
[TBL] [Abstract][Full Text] [Related]
11. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.
Royston I; Majda JA; Baird SM; Meserve BL; Griffiths JC
J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560
[TBL] [Abstract][Full Text] [Related]
12. [T- and B-lymphocytes in lymphoproliferative diseases].
Tsveibakh AS; Gol'dman EI
Vopr Onkol; 1978; 24(1):11-6. PubMed ID: 305684
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors.
Montanari F; O'Connor OA; Savage DG; Zain JM; Venkatraman S; McCormick EK; Crook MT; Tsao L; Sevilla DW; Bhagat G; Alobeid B
Hum Pathol; 2010 Aug; 41(8):1150-8. PubMed ID: 20381113
[TBL] [Abstract][Full Text] [Related]
14. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
15. Purine metabolism enzymes and immunological phenotype in chronic B-cell malignancies: chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia.
Babusíková O; Hrivnáková A; Klobusická M; Mesárosová A; Ujházy P
Neoplasma; 1990; 37(6):693-701. PubMed ID: 2125699
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the rosette test with neuraminidase-treated sheep red blood cells and acid phosphatase activity in lymphocytes from patients with lymphoproliferative disease.
Rudzka E; Hołowiecki J; Stella-Hołowiecka B; Krawczyk M
Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):223-7. PubMed ID: 312634
[TBL] [Abstract][Full Text] [Related]
17. [Mouse rosettes in the differential diagnosis of lymphoproliferative disorders].
Gabrielli A; Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
Minerva Med; 1982 May; 73(20):1383-90. PubMed ID: 7043323
[No Abstract] [Full Text] [Related]
18. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
19. T-lymphocyte colonies in normal blood, bone marrow and lymphoproliferative disorders.
Foa R; Catovsky D
Clin Exp Immunol; 1979 Jun; 36(3):488-95. PubMed ID: 314868
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of chronic lymphocytic leukemia from other "well to intermediate differentiated" lymphoproliferative disorders by the mouse rosette assay.
Hicks MJ; Grogan TM; Fielder K; Spier CM
Diagn Immunol; 1986; 4(1):31-6. PubMed ID: 3456864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
